Analyst Ratings for NxStage Medical (NXTM)

NXTM Rating Summary

NXTM Price Target Summary

* Over Last 12-Mos
  |   Expand Research on NXTM
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $12.00 (-17.9%) * Over Last 12-Mos
Date Firm Type Rating
(Past)
PT
(Past)
Start $ End $ % Chg. Details
3/11/2014 Wells Fargo Downgrade Underperform
(Market Perform)
11.00
(12.50)
14.66 14.62 -0.27% Details
7/26/2013 Lazard Capital Downgrade Neutral
(Buy)
N/A
(N/A)
13.59 14.62 7.58% Details
Like NXTM Ratings? Also take a look at FMS, SNN, RMTI, SSH

NXTM Ratings News